Update on the perioperative management of antiplatelets and anticoagulants in ophthalmic surgery

Herranz-Heras, J.C.; Alcalde-Blanco, L.; Cañas-Zamarra, Ignacio; Mencía‐Gutiérrez, Enrique; Ferro-Osuna, M.; Pérez-Trigo, Silvia

doi:10.1016/j.oftale.2020.11.001

Cited by 4 publications

(4 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The management approach for patients on anticoagulant therapy may vary depending on the specific procedure being performed, the individual patient's condition, and the surgeon's preference. 126,127 Devices specifically designed for canal-based MIGS procedures, such as the iStent and the Hydrus Microstent, have been linked to varying levels of hyphema risk. Nevertheless, it is important to note that the occurrence of hyphema associated with these devices is typically not considered to pose a threat to vision or result in surgical failure.…”

Section: Xen Gel Stentmentioning

confidence: 99%

“…The MIGS research community would greatly benefit from the establishment of a standardized definition for clinically significant hyphema for effective comparative analyses. 126,127 ' Conclusions MIGS encompasses a constantly evolving range of devices and procedures that aim to safely reduce IOP while improving the quality of life for patients by minimizing medication burden. Compared with traditional glaucoma surgeries, MIGS has demonstrated a lower incidence of sight-threatening complications, though the degree of IOP reduction is typically not as impressive.…”

Section: Xen Gel Stentmentioning

confidence: 99%

“…The impact of anticoagulant therapy on MIGS outcomes remains uncertain. The management approach for patients on anticoagulant therapy may vary depending on the specific procedure being performed, the individual patient’s condition, and the surgeon’s preference 126,127 . Devices specifically designed for canal-based MIGS procedures, such as the iStent and the Hydrus Microstent, have been linked to varying levels of hyphema risk.…”

Section: Anticoagulant Therapy and Migsmentioning

confidence: 99%

“…In addition, detailed information regarding hyphema events would be valuable—size, visual acuity at the time of diagnosis, and time to resolution with visual acuity measurements. The MIGS research community would greatly benefit from the establishment of a standardized definition for clinically significant hyphema for effective comparative analyses 126,127 …”

Section: Anticoagulant Therapy and Migsmentioning

confidence: 99%

See 3 more Smart Citations

Minimally Invasive Glaucoma Surgery

Gallo Afflitto,

Swaminathan

2023

International Ophthalmology Clinics

View full text Add to dashboard Cite

Section: Xen Gel Stentmentioning

confidence: 99%

Section: Xen Gel Stentmentioning

confidence: 99%

Section: Anticoagulant Therapy and Migsmentioning

confidence: 99%

Section: Anticoagulant Therapy and Migsmentioning

confidence: 99%

See 2 more Smart Citations

Minimally Invasive Glaucoma Surgery

Gallo Afflitto,

Swaminathan

2023

International Ophthalmology Clinics

View full text Add to dashboard Cite

Anticoagulant and Antiplatelet Agents in Oculoplastic Surgery

Quaranta Leoni,

Trobbiani,

Castela

et al. 2024

Oculoplastic, Lacrimal and Orbital Surgery

View full text Add to dashboard Cite

Intraoperative use of fibrin glue in blepharoplasty: a possible solution to reduce postoperative complication

Lee,

Chang

2023

Sci Rep

View full text Add to dashboard Cite

The purpose of this study was to investigate the effects of intraoperative fibrin glue use on surgery for blepharoptosis. This retrospective study included patients with acquired blepharoptosis who underwent surgical correction and were followed for at least one month. Patients were classified into two groups depending on whether treated with antithrombotic agents or otherwise. All patients taking antithrombotic agents discontinued with the treatment one week prior to surgery in accordance with our clinical guidelines. Preoperative and postoperative marginal reflex distance 1(MRD1) and ecchymosis grade were evaluated and compared. The subjects were 56 patients (111 eyes) who discontinued antithrombotic agents before surgery and 59 patients (117 eyes) who had never taken antithrombotic agents. Fibrin glue was used in 13 patients (26 eyes, 23.4%) in the antithrombotic group, and 11 patients (21 eyes, 17.9%) in the non-antithrombotic group. The rate of severe ecchymosis was significantly lower in patients who used fibrin glue in the antithrombotic group at 1 week (11.5 vs 40.0%, p = 0.008). However, in non-antithrombotic group, there was no difference in the rate of severe ecchymosis according to the use of fibrin glue at 1 week (14.3 vs 30.2%, p = 0.181). In patients with a history of taking antithrombotic agents, the intraoperative use of fibrin glue is thought to be helpful as it could significantly reduce significant ecchymosis.

show abstract

Update on the perioperative management of antiplatelets and anticoagulants in ophthalmic surgery

Cited by 4 publications

References 41 publications

Minimally Invasive Glaucoma Surgery

Minimally Invasive Glaucoma Surgery

Anticoagulant and Antiplatelet Agents in Oculoplastic Surgery

Intraoperative use of fibrin glue in blepharoplasty: a possible solution to reduce postoperative complication

Contact Info

Product

Resources

About